Literature DB >> 36074151

Cardiovascular Outcomes During Index Hospitalization in Children with Kawasaki Disease in Ontario, Canada.

Cal Robinson1, Megan Schlorff1, Rahul Chanchlani2,3, Anastasia Gayowsky4, Elizabeth Darling5, Tapas Mondal6, Hsien Seow7, Michelle Batthish8.   

Abstract

Kawasaki disease (KD) is a common childhood vasculitis associated with coronary artery aneurysms (CAA). However, there is limited published data on other cardiovascular events diagnosed during acute KD hospitalizations. Our objectives were to determine the incidence of cardiovascular events during acute KD hospitalizations, stratified by age at admission, CAA status, and pediatric intensive care unit (PICU) admission status. We identified all children (0-18 year) hospitalized with a new KD diagnosis in Ontario, between 1995 and 2018, through validated algorithms using population health administrative databases. We excluded children previously diagnosed with KD and non-Ontario residents. We evaluated for cardiovascular events that occurred during the acute KD hospitalizations, defined by administrative coding. Among 4597 children hospitalized with KD, 3307 (71.9%) were aged 0-4 years, median length of stay was 3 days (IQR 2-4), 113 children (2.5%) had PICU admissions, and 119 (2.6%) were diagnosed with CAA. During acute hospitalization, 75 children were diagnosed with myocarditis or pericarditis (1.6%), 47 with arrhythmias (1.0%), 25 with heart failure (0.5%), and ≤ 5 with acute MI (≤ 0.1%). Seven children underwent cardiovascular procedures (0.2%). Older children (10-18 years), children with CAA, and children admitted to the PICU were more likely to experience cardiovascular events, compared with children aged 0-4 years, without CAA or non-PICU admissions, respectively. The frequency of non-CAA cardiovascular events during acute KD hospitalizations did not change significantly between 1995 and 2018. During acute KD hospitalizations, older children, children with CAA, and PICU admissions are at higher risk of cardiovascular complications, justifying closer monitoring of these high-risk individuals.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Arrhythmia; Cardiovascular disease; Children; Coronary artery aneurysm; Kawasaki disease; Myocarditis

Year:  2022        PMID: 36074151     DOI: 10.1007/s00246-022-02997-8

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN: 0172-0643            Impact factor:   1.838


  32 in total

1.  Abnormal myocardial mechanics in Kawasaki disease: rapid response to gamma-globulin.

Authors:  A M Moran; J W Newburger; S P Sanders; I A Parness; P J Spevak; J C Burns; S D Colan
Journal:  Am Heart J       Date:  2000-02       Impact factor: 4.749

2.  Repeated systematic surveillance of Kawasaki disease in Ontario from 1995 to 2006.

Authors:  Yahui T Lin; Cedric Manlhiot; Joyce C Y Ching; Ra K Han; Lynne E Nield; Rejane Dillenburg; Dion Pepelassis; Lillian S Lai; John F Smythe; Nita Chahal; Rae S M Yeung; Brian W McCrindle
Journal:  Pediatr Int       Date:  2010-10       Impact factor: 1.524

3.  Noncoronary cardiac abnormalities are associated with coronary artery dilation and with laboratory inflammatory markers in acute Kawasaki disease.

Authors:  Beth F Printz; Lynn A Sleeper; Jane W Newburger; L LuAnn Minich; Timothy Bradley; Meryl S Cohen; Deborah Frank; Jennifer S Li; Renee Margossian; Girish Shirali; Masato Takahashi; Steven D Colan
Journal:  J Am Coll Cardiol       Date:  2011-01-04       Impact factor: 24.094

Review 4.  The epidemiology of Kawasaki disease: a global update.

Authors:  Surjit Singh; Pandiarajan Vignesh; David Burgner
Journal:  Arch Dis Child       Date:  2015-06-25       Impact factor: 3.791

5.  Epidemiology, Treatments, and Cardiac Complications in Patients with Kawasaki Disease: The Nationwide Survey in Japan, 2017-2018.

Authors:  Ryusuke Ae; Nobuko Makino; Koki Kosami; Masanari Kuwabara; Yuri Matsubara; Yosikazu Nakamura
Journal:  J Pediatr       Date:  2020-05-23       Impact factor: 4.406

Review 6.  Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association.

Authors:  Brian W McCrindle; Anne H Rowley; Jane W Newburger; Jane C Burns; Anne F Bolger; Michael Gewitz; Annette L Baker; Mary Anne Jackson; Masato Takahashi; Pinak B Shah; Tohru Kobayashi; Mei-Hwan Wu; Tsutomu T Saji; Elfriede Pahl
Journal:  Circulation       Date:  2017-03-29       Impact factor: 29.690

7.  Epidemiology of Kawasaki Disease in Canada 2004 to 2014: Comparison of Surveillance Using Administrative Data vs Periodic Medical Record Review.

Authors:  Cedric Manlhiot; Sunita O'Shea; Bailey Bernknopf; Michael LaBelle; Nita Chahal; Rejane F Dillenburg; Lillian S Lai; Dirk Bock; Brendan Lew; Sameer Masood; Mathew Mathew; Brian W McCrindle
Journal:  Can J Cardiol       Date:  2017-12-15       Impact factor: 5.223

Review 8.  When children with Kawasaki disease grow up: Myocardial and vascular complications in adulthood.

Authors:  John B Gordon; Andrew M Kahn; Jane C Burns
Journal:  J Am Coll Cardiol       Date:  2009-11-17       Impact factor: 24.094

Review 9.  Long-term management of Kawasaki disease: implications for the adult patient.

Authors:  Cedric Manlhiot; Elizabeth Niedra; Brian W McCrindle
Journal:  Pediatr Neonatol       Date:  2013-02-04       Impact factor: 2.083

10.  Kawasaki syndrome hospitalizations in the United States, 1997 and 2000.

Authors:  Robert C Holman; Aaron T Curns; Ermias D Belay; Claudia A Steiner; Lawrence B Schonberger
Journal:  Pediatrics       Date:  2003-09       Impact factor: 7.124

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.